LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 253 of 497
Next
>>
>
6301 to 6325 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
MCF7	Canertinib	0.04	uM	LJP6	1	H12	72	hr	1235	3789	4156	0.9117	0.8743
MCF7	Canertinib	0.04	uM	LJP6	2	H12	72	hr	1235	4091	4156	0.9843	0.9777
MCF7	Canertinib	0.04	uM	LJP6	3	H12	72	hr	1235	4263	4156	1.0257	1.0366
MCF7	Celastrol	0.04	uM	LJP6	1	G12	72	hr	1235	4491	4156	1.0806	1.1146
MCF7	Celastrol	0.04	uM	LJP6	2	G12	72	hr	1235	4566	4156	1.0986	1.1403
MCF7	Celastrol	0.04	uM	LJP6	3	G12	72	hr	1235	4427	4156	1.0652	1.0927
MCF7	CGP60474	0.04	uM	LJP5	1	F06	72	hr	1235	4521	4156	1.0878	1.1249
MCF7	CGP60474	0.04	uM	LJP5	2	F06	72	hr	1235	3978	4156	0.9571	0.9390
MCF7	CGP60474	0.04	uM	LJP5	3	F06	72	hr	1235	4134	4156	0.9947	0.9924
MCF7	CGP60474	0.04	uM	LJP6	1	G06	72	hr	1235	508	4156	0.1222	-0.2490
MCF7	CGP60474	0.04	uM	LJP6	2	G06	72	hr	1235	661	4156	0.1590	-0.1967
MCF7	CGP60474	0.04	uM	LJP6	3	G06	72	hr	1235	643	4156	0.1547	-0.2028
MCF7	CHIR-99021	0.04	uM	LJP6	1	P18	72	hr	1235	3571	4156	0.8592	0.7997
MCF7	CHIR-99021	0.04	uM	LJP6	2	P18	72	hr	1235	3437	4156	0.8270	0.7538
MCF7	CHIR-99021	0.04	uM	LJP6	3	P18	72	hr	1235	3688	4156	0.8874	0.8397
MCF7	CP724714	0.04	uM	LJP5	1	A12	72	hr	1235	3347	4156	0.8053	0.7230
MCF7	CP724714	0.04	uM	LJP5	2	A12	72	hr	1235	3088	4156	0.7430	0.6343
MCF7	CP724714	0.04	uM	LJP5	3	A12	72	hr	1235	3306	4156	0.7954	0.7089
MCF7	CP466722	0.04	uM	LJP5	1	I12	72	hr	1235	4735	4156	1.1393	1.1982
MCF7	CP466722	0.04	uM	LJP5	2	I12	72	hr	1235	4694	4156	1.1294	1.1841
MCF7	CP466722	0.04	uM	LJP5	3	I12	72	hr	1235	5124	4156	1.2329	1.3314
MCF7	Crizotinib	0.04	uM	LJP5	1	A24	72	hr	1235	3193	4156	0.7683	0.6702
MCF7	Crizotinib	0.04	uM	LJP5	2	A24	72	hr	1235	3111	4156	0.7485	0.6422
MCF7	Crizotinib	0.04	uM	LJP5	3	A24	72	hr	1235	3673	4156	0.8838	0.8346
MCF7	Momelotinib	0.04	uM	LJP5	1	P12	72	hr	1235	3439	4156	0.8275	0.7545

|<
<<
Previous
Page 253 of 497
Next
>>
>
6301 to 6325 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)